Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/04/2012CA2831820A1 Recombinant tnf ligand family member polypeptides with antibody binding domain and uses thereof
10/04/2012CA2831787A1 Buffer system for protein purification
10/04/2012CA2831770A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012CA2831732A1 Methods of administering beta7 integrin antagonists
10/04/2012CA2831603A1 Dual variable region antibody-like binding proteins having cross-over binding region orientation
10/04/2012CA2831454A1 Modulators of plexin b2 activity
10/04/2012CA2831415A1 Bispecific anti-cxcr7 immunoglobulin single variable domains
10/04/2012CA2831336A1 T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2
10/04/2012CA2831294A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012CA2831111A1 Cd37-binding molecules and immunoconjugates thereof
10/04/2012CA2830640A1 Novel protein purification methods
10/04/2012CA2830538A1 Anti - sclerostin antibody crystals and formulations thereof
10/04/2012CA2830442A1 Antibodies directed against icos and uses thereof
10/04/2012CA2830338A1 Antibody-drug conjugates
10/04/2012CA2829105A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/04/2012CA2828289A1 Antibody fc variants
10/04/2012CA2827817A1 Bispecific binding molecules binding to vegf and ang2
10/04/2012CA2827809A1 Bispecific binding molecules binding to dll4 and ang2
10/04/2012CA2827787A1 Anticoagulant antidotes
10/04/2012CA2812739A1 Hetero-dimeric immunoglobulins
10/03/2012EP2505654A1 Common light chain mouse
10/03/2012EP2505209A1 Fcgamma-RIIB-specific antibodies and methods of the use thereof
10/03/2012EP2505205A1 Anti-PDGFR Alpha Antibodies
10/03/2012EP2504364A1 Targeted binding agents against b7-h1
10/03/2012EP2504363A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
10/03/2012EP2504362A1 Anti-c5a binding moieties with high blocking activity
10/03/2012EP2504361A1 Marker protein for type 2 diabetes
10/03/2012EP2504360A1 Monomeric antibody fc
10/03/2012EP2504359A2 Monospecific polypeptide reagents
10/03/2012EP2504358A2 T cell receptors specific for immunodominant ctl epitopes of hcv
10/03/2012EP2504032A2 Antagonists of il-6 to prevent or treat thrombosis
10/03/2012EP2504031A2 Antibodies to il-6 and use thereof
10/03/2012EP2504030A2 Antagonists of il-6 to raise albumin and/or lower crp
10/03/2012CN1972714B Methods of treating autoimmune and inflammatory diseases
10/03/2012CN1946425B Target for B-cell disorders
10/03/2012CN1890266B Antibodies
10/03/2012CN1771053B Immunoglobulin formulation and method of preparation thereof
10/03/2012CN1646561B Gene conferring resistance to phytophthora infestans (late-blight) in solanacea
10/03/2012CN102712923A Anti-iga1 antibody
10/03/2012CN102712921A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
10/03/2012CN102712696A Coiled coil and/or tether containing protein complexes and uses thereof
10/03/2012CN102712695A Biological inhibitors of ROR1 capable of inducing cell death
10/03/2012CN102712694A Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene
10/03/2012CN102712693A Porphyromonas gingivalis polypeptides
10/03/2012CN102712692A RSV-specific binding molecule
10/03/2012CN102712691A Method to improve virus removal in protein purification
10/03/2012CN102712680A Modified steptococcus pneumonia pneumolysin (PLY) polypeptides
10/03/2012CN102712673A Chromatographic method for purifying fc-containing proteins
10/03/2012CN102711829A Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
10/03/2012CN102711828A Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
10/03/2012CN102711825A Dosage regimen for administering an EpCAMxCD3 bispecific antibody
10/03/2012CN102711822A Dosage regimen for administering a CD19xCD3 bispecific antibody
10/03/2012CN102711813A Anticoagulant antidotes
10/03/2012CN102711791A HIV related peptides combination or fusion for use in HIV vaccine composition or as diagnostic means
10/03/2012CN102711773A Inhibitors for growth hormone and related hormones, and methods of use thereof
10/03/2012CN102707063A Function of mini-chromosome maintenance complex component in disease diagnosis and prevention of systemic lupus erythematosus
10/03/2012CN102703470A Compositions and methods for modulating pigment production in plants
10/03/2012CN102703395A Enzymes associated with equol synthesis
10/03/2012CN102703388A Anti-human mCRP (monomeric C-reaction protein) monoclonal antibody, hybridoma cell lines and kit
10/03/2012CN102702359A Identification of novel igE epitopes
10/03/2012CN102702358A Antibody against the CSF-1 R
10/03/2012CN102702357A Recombination cyclophilin A antibody, preparation method thereof, enzyme-linked immuno sorbent assay (ELISA) kit and cell strains
10/03/2012CN102702356A Mouse DCF1 specific polyclonal antibody and preparation method of mouse DCF1 specific polyclonal antibody
10/03/2012CN102702355A Anti FGF23 antibody and a pharmaceutical composition comprising the same
10/03/2012CN102702354A Monoclonal antibody against human neurofilament medium molecular weight subunit and preparation method and application thereof
10/03/2012CN102702353A Anti-glypican 3 antibody
10/03/2012CN102702352A Human anti-EV71 virus neutralization antibody EV71FabL4 and preparation method and application thereof
10/03/2012CN102702351A Humanized EV71 antivirus neutralizing antibody EV71FabL6 and preparation method and application thereof
10/03/2012CN102702350A Monoclonal antibody of virus-resistance viral hemorrhagic septicemia virus G proteins and application of monoclonal antibody
10/03/2012CN102702349A Bactrian camel VHH (variable domain of the heavy chain of HACbs) heavy-chain antibody for resisting foot-and-mouth disease AsiaI type viruses, preparation method and use thereof
10/03/2012CN102702348A Monoclonal antibodies against Enterovirus 71 and uses thereof
10/03/2012CN102702347A Method for extracting immunoglobulin G from swine blood
10/03/2012CN102702345A Melamine antigen, related antibody and preparation method thereof
10/03/2012CN102702324A Application of human procalcitonin B cell epitope peptide fragment and monoclonal antibody thereof
10/03/2012CN102702323A Application of procalcitonin B cell epitope peptide fragment and monoclonal antibody thereof
10/03/2012CN102702322A H1 subtype specific conserved epitope, antibody and application thereof
10/03/2012CN102701972A Octachlorostyrene hapten, artificial antigen and specific antibody
10/03/2012CN102698265A Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
10/03/2012CN102698258A Composition and method for the treatment and prevention of enteric bacterial infections
10/03/2012CN102304182B Preparation method and use of enterotoxigenic Escherichia coli egg yolk antibody powder
10/03/2012CN102220286B Hybridoma cell strain 2C9, anti-aflatoxin M1 monoclonal antibody produced by hybridoma cell strain 2C9 and application thereof
10/03/2012CN102093479B Recombinant chimeric antibody of anti-human vascular endothelium growth factor receptor 2
10/03/2012CN102061287B Anti-human ppGa1NAc-T2 monoclonal antibody and application thereof
10/03/2012CN101962358B Ciprofloxacin hapten, artificial antigen and antibody and preparation method and application thereof
10/03/2012CN101955542B Immunoassay kit and special antibody for detecting fumonisins
10/03/2012CN101955541B Clenbuterol detection immunoassay kit and special antibody thereof
10/03/2012CN101857634B Activator protein for fibrinolytic system
10/03/2012CN101563366B Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
10/03/2012CN101505792B Tumor therapy with an anti-VEGF antibody
10/03/2012CN101454670B Method for measuring human megalin
10/03/2012CN101291693B Novel use of il-1beta compounds
10/03/2012CN101284874B Peptide-based immunization therapy for treatment of atherosclerosis
10/03/2012CN101011574B Use of an anti-il6 receptor antibody for preparing pharmaceutical composition
10/02/2012US8278498 Method for producing immortalised antibodies-secreting cells
10/02/2012US8278424 Antibodies that bind to PSCA proteins for diagnosis of cancer
10/02/2012US8278423 Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278421 Human antibodies specific for gastrin materials and methods
10/02/2012US8278420 Composition and method for prevention and treatment of type I diabetes
10/02/2012US8278269 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine